Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulant Therapy”

373 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 373 results

Testing effectiveness (Phase 2)Ended earlyNCT00673439
What this trial is testing

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
University of Louisville 3
Not applicableUnknownNCT00182117
What this trial is testing

Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population

Who this might be right for
BleedingEnd Stage Renal Disease
Hamilton Health Sciences Corporation 490
Not applicableUnknownNCT04291287
What this trial is testing

Triple or Dual Antithrombotic Therapy After PCI (TRIDUAL-PCI) Coronary Intervention in Patients With Non-valvular Atrial Fibrillation. Real-world Italian Multicenter Registry (TRIDUAL-PCI)

Who this might be right for
Atrial FibrillationMyocardial InfarctionAnticoagulant-induced Bleeding+1 more
Scientific Institute San Raffaele 1,500
Testing effectiveness (Phase 2)UnknownNCT05602129
What this trial is testing

A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects

Who this might be right for
Renal Replacement Therapy
Haisco Pharmaceutical Group Co., Ltd. 156
Large-scale testing (Phase 3)Study completedNCT00291330
What this trial is testing

Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism

Who this might be right for
Thromboembolism
Boehringer Ingelheim 2,564
Not applicableStudy completedNCT05471830
What this trial is testing

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

Who this might be right for
Prevention of Thromboembolic EventsAtrial Fibrillation
Bayer 600
Large-scale testing (Phase 3)Study completedNCT03395639
What this trial is testing

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Who this might be right for
Cardiac Disease
Daiichi Sankyo 168
Not applicableStudy completedNCT02559232
What this trial is testing

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

Who this might be right for
StrokePrevention and ControlAtrial Fibrillation
Bayer 247
Not applicableStudy completedNCT04412304
What this trial is testing

Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients

Who this might be right for
Covid-19Thromboembolic EventsBleeding
Karolinska Institutet 166
Not applicableStudy completedNCT03182829
What this trial is testing

In Vitro Diagnostic Test for DOAC in Urine

Who this might be right for
Anticoagulant Therapy
Doasense GmbH 880
Not applicableStudy completedNCT03264937
What this trial is testing

Social-software iMproving wARfarin Therapy

Who this might be right for
Anticoagulants Causing Adverse Effects in Therapeutic UsePatient Compliance
Wuhan Asia Heart Hospital 735
Post-approval studies (Phase 4)Active Not RecruitingNCT07185295
What this trial is testing

Short-term Interruption Versus Continuous Anticoagulation in Colorectal Polypectomy

Who this might be right for
Anticoagulated Patients
Outcomes'10 481
Large-scale testing (Phase 3)UnknownNCT02221102
What this trial is testing

Edoxaban for TIA and Acute Minor Stroke

Who this might be right for
IschemiaStrokeCerebral Infarction
Xijing Hospital 3,700
Post-approval studies (Phase 4)Study completedNCT04006288
What this trial is testing

Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
University of Florida 90
Not applicableStudy completedNCT04153591
What this trial is testing

Efficacy and Safety of Direct Oral Anticoagulants for the Treatment of Mural Thrombus

Who this might be right for
Acute Myocardial Infarction
Methodist Health System 75
Not applicableLooking for participantsNCT06487052
What this trial is testing

Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients

Who this might be right for
Pulmonary Embolism Acute
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 100
Not applicableUnknownNCT03392948
What this trial is testing

PERcutaneouS Coronary intErventions in Patients Treated With Oral Anticoagulant Therapy

Who this might be right for
Acute Myocardial InfarctionUnstable AnginaChronic Stable Angina
Italian Society of Invasive Cardiology 1,080
Post-approval studies (Phase 4)Study completedNCT04173429
What this trial is testing

Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis

Who this might be right for
Liver CirrhosisPortal Vein Thrombosis
Qilu Hospital of Shandong University 64
Post-approval studies (Phase 4)Study completedNCT01452568
What this trial is testing

Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirin

Who this might be right for
ThromboembolismBleeding
Rigshospitalet, Denmark 370
Not applicableStudy completedNCT02849509
What this trial is testing

Patient Convenience Study- NIS RELATE

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,313
Next Page